Double maintains 1 strategies that include FDMT - 4D Molecular Therapeutics, Inc.
Finnhub
Initial interim 52-week results from Phase 2b Population Extension cohort of PRISM clinical trial to be presented by Dante Pieramici, M.D., a Principal Investigator in PRISM, at Angiogenesis,...
Finnhub
NEW YORK, Jan. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of 4D Molecular Therapeutics, Inc. . Such investors are advised to contact Danielle Peyton at...
Yahoo
Strategically focused pipeline optimizes resource allocation to progress two product candidates with strongest clinical proof of concept: 4D-150 for wet AMD and DME and 4D-710 for cystic fibrosisAfter alignment with FDA and EMA on trial designs for the 4D-150 Phase 3 4FRONT program in wet AMD, 4FRONT-1 and 4FRONT-2 trials on track to initiate in Q1 2025 and Q3 2025 respectivelyPrimary endpoint 52-week topline data for both 4FRONT-1 and 4FRONT-2 expected in H2 2027Cash runway extended under updat
Yahoo
Across all DME patients dosed to date, 4D-150 continues to be well tolerated with no intraocular inflammation observed at any timepoint or dose level3E10 vg/eye demonstrated strong signals of clinical activity with sustained gain of BCVA of +8.4 letters and reduction of CST of -194 µm from baseline through Week 323E10 vg/eye achieved an 86% reduction in injection burden vs. projected on-label aflibercept 2mg Q8W and dose response with 61% reduction vs. 1E10 vg/eye, with 0.6 mean supplemental inj
Finnhub
Intravitreal 4D-150 DME Clinical Trial: Part 1 Interim 32-week Results January 10, 2025 © 2025 4D...
Finnhub
4D Molecular Therapeutics, Inc. dropped from S&P Biotechnology Select Industry Index...
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -17.06% | $195.31M | 0.85% |
BTAL | -14.28% | $272.15M | 1.43% |
TAIL | -13.11% | $65.47M | 0.59% |
TPMN | -12.04% | $33.98M | 0.65% |
FTXG | -10.82% | $21.86M | 0.6% |
TAXF | -10.31% | $524.56M | 0.29% |
SHYD | -10.25% | $320.50M | 0.35% |
FMHI | -9.59% | $780.99M | 0.7% |
CCOR | -9.31% | $71.42M | 1.18% |
PWZ | -8.24% | $719.43M | 0.28% |
USO | -7.92% | $1.07B | 0.6% |
IYK | -7.60% | $1.21B | 0.4% |
MMIT | -7.39% | $820.45M | 0.3% |
AGZD | -7.37% | $137.11M | 0.23% |
FLIA | -7.36% | $621.08M | 0.25% |
HYD | -7.14% | $3.27B | 0.32% |
BNO | -6.86% | $96.30M | 1% |
DRLL | -6.84% | $313.29M | 0.41% |
WEAT | -6.61% | $124.48M | 0.28% |
IBDQ | -6.42% | $3.18B | 0.1% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
INFL | -<0.01% | $1.10B | 0.85% |
UPAR | -0.01% | $63.34M | 0.65% |
ASHR | 0.02% | $2.40B | 0.65% |
UTWO | 0.03% | $386.83M | 0.15% |
REMX | -0.03% | $237.01M | 0.56% |
VPU | 0.04% | $6.68B | 0.1% |
FXB | -0.06% | $48.12M | 0.4% |
JCPB | -0.06% | $5.37B | 0.38% |
BSCQ | 0.10% | $4.25B | 0.1% |
PXJ | -0.11% | $39.72M | 0.66% |
CGCB | -0.13% | $1.79B | 0.27% |
IUSB | 0.13% | $32.46B | 0.06% |
GVI | 0.13% | $3.28B | 0.2% |
KMLM | 0.14% | $323.07M | 0.9% |
ILTB | -0.14% | $608.44M | 0.06% |
SCHP | -0.15% | $11.74B | 0.03% |
BIV | -0.15% | $21.50B | 0.04% |
AGGH | 0.16% | $261.74M | 0.29% |
CGSM | -0.17% | $588.41M | 0.25% |
MTBA | 0.20% | $1.51B | 0.17% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
TECK | -<0.01% | $21.57B | +13.16% | 0.84% |
FRSH | -<0.01% | $5.56B | -14.04% | 0.00% |
CF | 0.02% | $14.64B | +9.95% | 2.39% |
DOLE | 0.03% | $1.31B | +25.09% | 2.33% |
RRC | -0.03% | $9.08B | +32.22% | 0.85% |
DBRG | -0.04% | $1.90B | -45.15% | 0.37% |
KR | -0.04% | $46.97B | +42.85% | 1.88% |
EGO | 0.06% | $2.87B | +15.21% | 0.00% |
DLTR | 0.06% | $16.02B | -47.11% | 0.00% |
SUP | -0.07% | $56.33M | -38.87% | 0.00% |
DRH | -0.07% | $1.82B | -3.17% | 3.67% |
CPSH | 0.07% | $24.98M | -27.73% | 0.00% |
PRVA | -0.08% | $2.72B | +11.77% | 0.00% |
TGT | 0.08% | $61.71B | -8.63% | 3.30% |
MNST | -0.08% | $45.03B | -18.04% | 0.00% |
NWE | -0.09% | $3.28B | +13.72% | 4.85% |
EGP | -0.09% | $8.58B | -6.26% | 3.05% |
PTON | -0.09% | $3.24B | +87.42% | 0.00% |
BHR | 0.09% | $176.95M | +23.72% | 7.55% |
COCO | 0.09% | $2.12B | +85.03% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
APD | -43.03% | $72.97B | +49.21% | 2.22% |
MCD | -18.49% | $210.94B | +0.83% | 2.30% |
GIS | -15.05% | $32.65B | -7.52% | 4.03% |
VZ | -15.05% | $168.13B | +0.08% | 6.74% |
CAG | -14.87% | $11.94B | -11.00% | 5.57% |
CBOE | -14.57% | $21.67B | +12.40% | 1.15% |
DMLP | -14.52% | $1.49B | +4.84% | 10.33% |
K | -14.50% | $28.31B | +49.49% | 2.75% |
KDP | -14.38% | $42.05B | -1.56% | 2.86% |
VIRT | -14.03% | $3.46B | +142.02% | 2.41% |
TXO | -13.43% | $775.72M | +5.63% | 12.55% |
QLYS | -13.27% | $5.15B | -17.06% | 0.00% |
CPB | -12.97% | $11.17B | -13.04% | 3.98% |
FDP | -12.81% | $1.50B | +30.66% | 3.20% |
JBSS | -12.41% | $821.88M | -27.25% | 1.20% |
HRL | -12.36% | $16.02B | -0.98% | 3.89% |
SJM | -12.03% | $10.98B | -21.28% | 4.13% |
ADM | -12.00% | $21.80B | -13.57% | 4.39% |
CME | -12.00% | $88.08B | +19.81% | 4.26% |
CVGW | -11.31% | $404.91M | -15.61% | 2.64% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
NSSC | 38.50% | $967.91M | -41.73% | 1.69% |
SUNS | 35.25% | $81.79M | +4.51% | 5.34% |
IDXX | 34.88% | $37.71B | -19.71% | 0.00% |
LUCK | 34.78% | $1.64B | -24.49% | 2.00% |
CNA | 30.69% | $13.45B | +14.48% | 3.55% |
COGT | 28.60% | $1.01B | +43.73% | 0.00% |
SWTX | 28.54% | $2.92B | -15.40% | 0.00% |
IMVT | 27.80% | $3.46B | -42.27% | 0.00% |
RVMD | 27.03% | $7.94B | +43.42% | 0.00% |
APLS | 26.95% | $3.76B | -55.67% | 0.00% |
GHM | 26.76% | $514.87M | +106.10% | 0.00% |
SPHR | 26.30% | $1.70B | +16.57% | 0.00% |
ATXS | 25.92% | $420.43M | -51.18% | 0.00% |
KYMR | 25.65% | $2.53B | +14.89% | 0.00% |
IMNM | 25.61% | $967.83M | -51.34% | 0.00% |
ON | 25.55% | $22.33B | -35.03% | 0.00% |
KOD | 25.53% | $297.85M | +7.40% | 0.00% |
RYTM | 25.10% | $3.69B | +26.20% | 0.00% |
CLDX | 23.93% | $1.55B | -37.93% | 0.00% |
AMG | 23.51% | $5.52B | +18.43% | 0.02% |
Current Value
$6.601 Year Return
Current Value
$6.601 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CPRJ | 32.40% | $51.17M | 0.69% |
XBI | 29.20% | $6.19B | 0.35% |
PTH | 28.60% | $130.98M | 0.6% |
GNOM | 26.41% | $71.39M | 0.5% |
IBB | 24.38% | $6.68B | 0.45% |
PINK | 22.99% | $145.96M | 0.5% |
IHE | 22.64% | $619.42M | 0.39% |
IWC | 22.39% | $977.29M | 0.6% |
XPH | 22.20% | $167.37M | 0.35% |
CPNJ | 22.08% | $34.66M | 0.69% |
ARKG | 21.95% | $1.25B | 0.75% |
CPSJ | 21.04% | $38.01M | 0.69% |
IBD | 20.50% | $337.91M | 0.44% |
XDTE | 19.82% | $390.23M | 0.95% |
BBH | 19.70% | $408.55M | 0.35% |
RSPA | 19.68% | $274.94M | 0% |
FFTY | 19.67% | $76.56M | 0.8% |
IWO | 19.23% | $12.87B | 0.24% |
EWN | 19.12% | $274.99M | 0.5% |
PFUT | 19.05% | $352.66M | 0.64% |